Search

CorMedix Inc

Gesloten

SectorGezondheidszorg

7.88 0.77

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

7.73

Max

7.9399999999999995

Belangrijke statistieken

By Trading Economics

Inkomsten

-77M

-39M

Verkoop

-25M

102M

K/W

Sectorgemiddelde

3.867

56.597

EPS

0.29

Winstmarge

-37.87

Werknemers

191

EBITDA

-8.8M

57M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+78.91% upside

Dividenden

By Acuity

Volgende Winsten

11 nov 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

66M

657M

Vorige openingsprijs

7.11

Vorige sluitingsprijs

7.88

Nieuwssentiment

By Acuity

71%

29%

300 / 339 Rangschikking in Healthcare

CorMedix Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

11 sep 2026, 22:31 UTC

CorMedix Inc shares are higher in after-market trading. No specific news was identified to explain the price movement, though broader market dynamics may be influencing sentiment.

9 sep 2026, 19:54 UTC

CorMedix Inc shares are lower amid a broader market decline influenced by rising crude oil prices and inflation concerns, as noted by UBS.

8 sep 2026, 20:51 UTC

CorMedix Inc. shares declined in after-market trading, breaking a trend of higher daily closes. Broader market concerns include inflation driven by rising oil prices.

3 sep 2026, 19:47 UTC

CorMedix Inc's shares are lower today, declining despite easing Treasury yields. The stock has pulled back from earlier session lows amid no specific news.

2 sep 2026, 21:01 UTC

CorMedix Inc's shares are higher in after-market trading, remaining above their 20-day moving average after rebounding from an earlier session low.

1 sep 2026, 23:01 UTC

CorMedix Inc. shares declined after-market, reversing an initial uptick. The stock remains above its 20-day moving average and near the upper end of its one-month range.

31 aug 2026, 19:46 UTC

CorMedix Inc's shares are lower amid broader market unease following hawkish comments from Federal Reserve Chair Kevin Warsh at the Jackson Hole symposium.

28 aug 2026, 23:01 UTC

CorMedix Inc shares declined in after-market trading, reversing from a high of 0.84% to a low of -1.45% without any specific news identified.

27 aug 2026, 23:16 UTC

CorMedix Inc shares are higher in after-market trading, remaining above their 20-day moving average amid mixed sentiment in US markets.

26 aug 2026, 20:08 UTC

CorMedix Inc shares are lower amid a broader decline in the Pharmaceuticals sub-sector. The stock remains above its 20-day moving average.

25 aug 2026, 23:51 UTC

CorMedix Inc shares settled higher in after-market trading, supported by a favorable market environment amid declining crude oil prices.

24 aug 2026, 23:01 UTC

CorMedix Inc shares are higher in after-market trading, reaching a high of 1.09% above Monday's close, significantly above their 20-day moving average.

21 aug 2026, 19:56 UTC

CorMedix Inc. shares are lower, pulling back from earlier gains amid no specific news. The stock remains near the upper end of its one-month range.

20 aug 2026, 23:01 UTC

CorMedix Inc. shares are lower in after-market trading, following broader market declines driven by significant losses in major companies like Walmart Inc.

19 aug 2026, 23:06 UTC

CorMedix Inc shares are lower in after-market hours, declining from Wednesday's close after initially pulling back from an earlier high. No specific news was identified.

18 aug 2026, 23:16 UTC

CorMedix Inc shares are lower in after-market trading following Tuesday's close, with no specific news identified to explain the movement.

17 aug 2026, 23:31 UTC

CorMedix Inc shares are higher in after-hours trading, advancing since Monday's close. The stock is trading above its 20-day moving average.

14 aug 2026, 21:41 UTC

CorMedix Inc shares are higher in after-market trading following Friday's close, despite a slight decline earlier in the session. No specific news was identified.

13 aug 2026, 23:01 UTC

CorMedix Inc's shares are higher in after-market trading, fluctuating between a high of 0.74% and a low of -1.23%. No specific news was identified.

12 aug 2026, 23:31 UTC

CorMedix Inc's shares rose in after-market trading, recovering from an earlier decline despite remaining below the 20-day moving average.

11 aug 2026, 23:46 UTC

CorMedix Inc. shares are higher in after-market trading, reflecting routine activity. The stock remains below its 20-day moving average.

10 aug 2026, 19:46 UTC

Shares of CorMedix Inc. are higher today amid broader market uncertainty following last Friday's U.S. employment report and ahead of the Consumer Price Index release.

7 aug 2026, 23:02 UTC

News

CorMedix Inc. received preliminary court approval for a derivative settlement, contributing to positive sentiment as shares rose in after-market trading.

6 aug 2026, 22:01 UTC

CorMedix Inc shares are lower in after-market trading, diverging from their flat position at market close. No specific news was identified to explain the decline.

5 aug 2026, 19:46 UTC

CorMedix shares are lower as broader market sentiment reflects disappointing ADP employment data, which showed a significant miss in private sector job growth.

4 aug 2026, 21:26 UTC

CorMedix Inc. shares were roughly flat in after-market hours, remaining effectively unchanged since Tuesday's close and 5.89% below the 20-day moving average.

3 aug 2026, 23:01 UTC

CorMedix Inc shares advanced in after-market trading, recovering from an earlier decline. The stock remains below its 20-day moving average and one-month range.

31 jul 2026, 22:01 UTC

CorMedix Inc shares are lower in after-market hours, continuing a trend of weak trading. The stock is near its one-month low and below its 20-day average.

30 jul 2026, 20:08 UTC

CorMedix Inc shares are trading higher, reflecting a notable early spike despite broader market volatility and mixed economic signals.

29 jul 2026, 19:27 UTC

CorMedix Inc shares are lower today, continuing a four-session decline. The asset reached a session high before dropping to midday lows.

Peer Vergelijking

Prijswijziging

CorMedix Inc Prognose

Koersdoel

By TipRanks

78.91% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 14 USD  78.91%

Hoogste 15 USD

Laagste 13 USD

Gebaseerd op 3 Wall Street-analisten die 12-maands prijsdoelen bieden voor CorMedix Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

3 ratings

3

Buy

0

Hold

0

Sell

Sentiment

By Acuity

300 / 339 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
help-icon Live chat